20
Participants
Start Date
March 1, 2017
Primary Completion Date
December 31, 2020
Study Completion Date
December 31, 2025
ICAR19 CAR-T cells
T cells were isolated from peripheral blood from patients enrolled. T cells were transduced with lentivirus bearing anti-CD19 antibody scFV and the activation signals of second generation CART designation. The CART cells were infused into the patients by IV with an escalating dosage.
RECRUITING
Weifang People's Hospital, Weifang
Lead Sponsor
Weifang People's Hospital
OTHER
Immune Cell, Inc.
INDUSTRY